RxDoctor Payments DataLook up a doctor →

Paulette Johnson

Family · West Memphis, ARNPI 1508308131

Payments from drug & device makers

$15,053in general payments, 2019–2025

Across 703 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Johnson & Johnson$953
  • Seagen Inc.$738
  • Novartis$692
  • AbbVie$675
  • Takeda Pharmaceuticals U.S.A., Inc.$634
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)55$1,625
Johnson & Johnson(2 entities)58$953
Seagen Inc.38$738
Novartis37$692
AbbVie22$675
Takeda Pharmaceuticals U.S.A., Inc.23$634
Merck25$560
E.r. Squibb & Sons, L.L.C.27$542
Astellas Pharma US Inc14$523
Amgen25$491
GSK25$488
Gilead24$488
Regeneron Healthcare Solutions, Inc.10$455
Daiichi Sankyo Inc.20$404
Eisai Inc.23$398
Lilly USA, LLC19$378
Stemline Therapeutics Inc.7$367
Beigene USA, Inc.13$319
Pfizer17$288
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$246
Bristol Myers Squibb11$238
Genentech USA, Inc.16$229
Rigel Pharmaceuticals, Inc.13$208
Exelixis Inc.11$201
Sanofi8$173
Taiho Oncology, Inc.10$165
Kyowa Kirin, Inc.9$155
ADC Therapeutics America, Inc.8$142
Novo Nordisk2$140
Sobi, Inc7$137
Incyte Corporation6$120
Morphosys, US Inc.3$105
Array Biopharma Inc5$101
Adaptive Biotechnologies Corporation5$96
Beone Medicines USA, Inc.4$95
Genmab U.S., Inc.4$94
Pharmacosmos Therapeutics Inc.5$85
Bayer5$80
AVEO Pharmaceuticals, Inc.4$76
Mirati Therapeutics, Inc.4$76
Sumitomo Pharma America, Inc.3$73
EMD Serono, Inc.3$71
G1 Therapeutics, Inc.5$64
Boston Scientific3$55
Pharmaessentia USA Corporation3$55
Coherus Oncology, Inc.4$53
Dova Pharmaceuticals3$52
Jazz Pharmaceuticals Inc.3$51
Acrotech Biopharma Inc.3$50
Karyopharm Therapeutics Inc.3$48
Servier Pharmaceuticals LLC3$48
Tersera Therapeutics LLC2$42
Myovant Sciences Inc.3$38
Spectrum Pharmaceuticals Inc.2$38
Puma Biotechnology, Inc.2$34
AMAG Pharmaceuticals, Inc.2$34
Secura Bio, Inc.2$32
Azurity Pharmaceuticals, Inc.1$30
Pharmacyclics LLC, An Abbvie Company2$25
Geron Corporation1$20

How this compares

$15,053 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas →

Medicare billing

Part B allowed, 2024
$75,749
Medicare patients
182
Services billed
1,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in West Memphis

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →